-+ 0.00%
-+ 0.00%
-+ 0.00%

CIPLA ANNOUNCES EXCLUSIVE PARTNERSHIP WITH QILU PHARMACEUTICAL FOR THE LICENSING AND SUPPLY OF BIOSIMILAR TO KEYTRUDA® (PEMBROLIZUMAB) IN THE US

Reuters·09/03/2026 16:24:15

Please log in to view news